J
Jorge L. Juncos
Researcher at Emory University
Publications - 91
Citations - 8365
Jorge L. Juncos is an academic researcher from Emory University. The author has contributed to research in topics: Parkinson's disease & Population. The author has an hindex of 41, co-authored 88 publications receiving 7690 citations.
Papers
More filters
Journal ArticleDOI
Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.
Clifford W. Shults,David Oakes,Karl Kieburtz,M. Flint Beal,Richard H. Haas,Sandy Plumb,Jorge L. Juncos,John G. Nutt,Ira Shoulson,Julie H. Carter,Katie Kompoliti,Joel S. Perlmutter,Stephen G. Reich,Matthew B. Stern,Ray L. Watts,Roger Kurlan,Eric Molho,Madaline B. Harrison,Mark F. Lew +18 more
TL;DR: Coenzyme Q10 appears to slow the progressive deterioration of function in PD, but these results need to be confirmed in a larger study.
Journal ArticleDOI
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy
Günter U. Höglinger,Nadine M. Melhem,Dennis W. Dickson,Patrick M. A. Sleiman,Li-San Wang,Lambertus Klei,Rosa Rademakers,Rohan de Silva,Irene Litvan,David E. Riley,John C. van Swieten,Peter Heutink,Zbigniew K. Wszolek,Ryan J. Uitti,Jana Vandrovcova,Howard I. Hurtig,Rachel G. Gross,Walter Maetzler,Stefano Goldwurm,Eduardo Tolosa,Barbara Borroni,Pau Pastor,Laura B. Cantwell,Mi Ryung Han,Allissa Dillman,Marcel P. van der Brug,J. Raphael Gibbs,J. Raphael Gibbs,Mark R. Cookson,Dena G. Hernandez,Dena G. Hernandez,Andrew B. Singleton,Matthew J. Farrer,Chang En Yu,Lawrence I. Golbe,Tamas Revesz,John Hardy,Andrew J. Lees,Bernie Devlin,Hakon Hakonarson,Ulrich Müller,Gerard D. Schellenberg,Roger L. Albin,Elena Alonso,Angelo Antonini,Manuela Apfelbacher,Steven E. Arnold,Jesús Avila,Thomas G. Beach,Sherry Beecher,Daniela Berg,Thomas D. Bird,Nenad Bogdanovic,Agnita J.W. Boon,Yvette Bordelon,Alexis Brice,Alexis Brice,Herbert Budka,Margherita Canesi,Wang Zheng Chiu,Roberto Cilia,Carlo Colosimo,Peter Paul De Deyn,Justo Garcãa De Yebenes,Laura Donker Kaat,Ranjan Duara,Alexandra Durr,Alexandra Durr,Sebastiaan Engelborghs,Giovanni Fabbrini,Nicole A. Finch,Robyn Flook,Matthew P. Frosch,Carles Gaig,Douglas Galasko,Thomas Gasser,Marla Gearing,Evan T. Geller,Bernardino Ghetti,Neill R. Graff-Radford,Murray Grossman,Deborah A. Hall,Lili-Naz Hazrati,Matthias Höllerhage,Joseph Jankovic,Jorge L. Juncos,Anna Karydas,Hans A. Kretzschmar,Isabelle Leber,Isabelle Leber,Virginia M.-Y. Lee,Andrew P. Lieberman,Kelly E. Lyons,Claudio Mariani,Eliezer Masliah,Luke A. Massey,Catriona McLean,Nicoletta Meucci,Bruce L. Miller,Brit Mollenhauer,Jens Carsten Möller,Huw R. Morris,Christopher Morris,Sean S. O'Sullivan,Wolfgang H. Oertel,Donatella Ottaviani,Alessandro Padovani,Rajesh Pahwa,Gianni Pezzoli,Stuart Pickering-Brown,Werner Poewe,Alberto Rábano,Alex Rajput,Stephen G. Reich,Gesine Respondek,Sigrun Roeber,Jonathan D. Rohrer,Owen A. Ross,Martin N. Rossor,Giorgio Sacilotto,William W. Seeley,Klaus Seppi,Laura Silveira-Moriyama,Salvatore Spina,Karin Srulijes,Peter St George-Hyslop,Maria Stamelou,David G. Standaert,Silvana Tesei,Wallace W. Tourtellotte,Claudia Trenkwalder,Claire Troakes,John Q. Trojanowski,Juan C. Troncoso,Vivianna M. Van Deerlin,Jean Paul G. Vonsattel,Gregor K. Wenning,Charles L. White,Pia Winter,Chris Zarow,Anna Zecchinelli +140 more
TL;DR: Two independent variants in MAPT affecting risk for PSP are confirmed, one of which influences MAPT brain expression and the genes implicated encode proteins for vesicle-membrane fusion at the Golgi-endosomal interface and for a myelin structural component.
Journal ArticleDOI
Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients
John M. Shoffner,Michael D. Brown,Antonio Torroni,Marie T. Lott,Margaret F. Cabell,Suzanne S. Mirra,M. Flint Beal,Chi Chuan Yang,Marla Gearing,Rino Salvo,Ray L. Watts,Jorge L. Juncos,Lawrence A. Hansen,Barbara J. Crain,Michel Fayad,Calvin L. Reckord,Douglas C. Wallace +16 more
TL;DR: Mitochondrial DNA variants associated with Alzheimer disease (AD) and Parkinson disease (PD) were sought by restriction endonuclease analysis in a cohort of 71 late-onset Caucasian patients and one patient harbored an additional novel 12S rRNA 5-nucleotide insertion at np 956-965.
Journal ArticleDOI
Mitochondrial oxidative phosphorylation defects in Parkinson's disease
TL;DR: It is concluded that Parkinson's disease is a systemic disorder of Oxphos, probably of a complex genetic etiology, and premature cell death in the nigrostriatal dopamine pathway could be due to energetic impairment and accentuated free radical generation caused by anOxphos defect.
Journal ArticleDOI
Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders
Valerie Voon,Pierre-Olivier Fernagut,Jeff Wickens,Christelle Baunez,Manuel Rodriguez,Manuel Rodriguez,Nancy Pavón,Jorge L. Juncos,Jose A. Obeso,Jose A. Obeso,Erwan Bezard +10 more
TL;DR: Clinical features, overlapping molecular mechanisms, and a specific cognitive mechanism of habit learning that might underlie these behaviours are reviewed and integrated with the emerging view of the basal ganglia as a distributive system involved in the selection and facilitation of movements, acts, and emotions.